Cohen & Steers (CNS - Free Report) reported preliminary assets under management (AUM) of $69.6 billion as of Aug 31, 2019, up 3% from the prior-month level of $67.5 billion. Market appreciation of $2 billion and net inflows of $240 million were partly offset by distributions of $186 million.
Both July and August AUM balance included model-based portfolios, which were previously classified as assets under advisement. These portfolios, totaling $4.4 billion as of Jul 31, 2019, are managed within discretionary accounts and associated revenues are included in portfolio consulting and other.
The company recorded total institutional accounts of $30.9 billion at the end of the month, up 2.8% on a sequential basis. Of the total institutional accounts, advisory accounts were $14.5 billion as of Aug 31 while the remaining were subadvisory accounts.
Cohen & Steers recorded $29 billion in open-end funds, up 3.8% from the $27.9 billion recorded a month ago. Also, closed-end funds were $9.6 billion, up 1.7% from July 2019.
With operations across the globe, the company benefits largely from its well-diversified AUM. However, escalating expenses mainly due to its continued expansion efforts will keep hindering its bottom-line growth.
Shares of the company have surged 53.4% so far this year compared with 14.2% rally of the industry.
Currently, Cohen & Steers carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance and Upcoming Releases
Franklin Resources (BEN - Free Report) announced preliminary AUM by its subsidiaries of $690.6 billion for August 2019. Results displayed 2.7% decrease from $709.5 billion recorded as of Jul 31, 2019. Net outflows and net market declines led to this downside.
Invesco (IVZ - Free Report) and AllianceBernstein Holding L.P. (AB - Free Report) are expected to report August AUM figures in the next few days.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Cohen & Steers (CNS - Free Report) reported preliminary assets under management (AUM) of $69.6 billion as of Aug 31, 2019, up 3% from the prior-month level of $67.5 billion. Market appreciation of $2 billion and net inflows of $240 million were partly offset by distributions of $186 million.
Both July and August AUM balance included model-based portfolios, which were previously classified as assets under advisement. These portfolios, totaling $4.4 billion as of Jul 31, 2019, are managed within discretionary accounts and associated revenues are included in portfolio consulting and other.
The company recorded total institutional accounts of $30.9 billion at the end of the month, up 2.8% on a sequential basis. Of the total institutional accounts, advisory accounts were $14.5 billion as of Aug 31 while the remaining were subadvisory accounts.
Cohen & Steers recorded $29 billion in open-end funds, up 3.8% from the $27.9 billion recorded a month ago. Also, closed-end funds were $9.6 billion, up 1.7% from July 2019.
With operations across the globe, the company benefits largely from its well-diversified AUM. However, escalating expenses mainly due to its continued expansion efforts will keep hindering its bottom-line growth.
Shares of the company have surged 53.4% so far this year compared with 14.2% rally of the industry.
Currently, Cohen & Steers carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance and Upcoming Releases
Franklin Resources (BEN - Free Report) announced preliminary AUM by its subsidiaries of $690.6 billion for August 2019. Results displayed 2.7% decrease from $709.5 billion recorded as of Jul 31, 2019. Net outflows and net market declines led to this downside.
Invesco (IVZ - Free Report) and AllianceBernstein Holding L.P. (AB - Free Report) are expected to report August AUM figures in the next few days.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on BEN - FREE
Get the latest research report on IVZ - FREE
Get the latest research report on AB - FREE
Get the latest research report on CNS - FREE